It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The epidemiology of vertebral fractures (VF) in underrepresented populations is not well-documented. This cohort study was part of a longitudinal osteoporosis research project with the aim of determining the prevalence, incidence, and risk factors for VF. 401 individuals (155 men) aged 50 years and older without a clinical diagnosis of VF were took radiographs at baseline and 2 years later. VF were ascertained using the Genant's semi-quantitative method. Bone mineral density (BMD) of femoral neck and lumbar spine were measured by dual-energy X-ray absorptiometry (Hologic Inc). The association between VF and risk factors was analyzed by the multiple logistic regression. The 95% confidence interval for prevalence and incidence was estimated by exact Poisson test. At baseline, the prevalence of VF was 12.2% (n = 49, 95% CI 9.0–16.2%) and increased with advancing age with one-fifth of those aged 70 and older having a VF. During the follow-up period, we observed 6 new VF, making the incidence of 6.6/1000 person-years (n = 6, 95% CI 2.4–14.3). The risk of prevalent VF was associated with male gender (OR: 2.67; 95% CI 1.28–5.87) and T-score at the femoral neck (OR per one SD decrease: 1.1; 1.03–1.17). These data indicate that VF is common among adults, and that lower femoral neck BMD was a risk factor for VF.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 University of Medicine and Pharmacy, Hue University, Department of Internal Medicine, Hue, Vietnam (GRID:grid.440798.6); Can Tho University of Medicine and Pharmacy, Faculty of Medicine, Can Tho, Vietnam (GRID:grid.440798.6) (ISNI:0000 0004 0576 9556); Saigon Precision Medicine Research Center, Ho Chi Minh City, Vietnam (GRID:grid.440798.6)
2 Can Tho University of Medicine and Pharmacy, Faculty of Medicine, Can Tho, Vietnam (GRID:grid.440798.6) (ISNI:0000 0004 0576 9556)
3 University of Medicine and Pharmacy, Hue University, Department of Internal Medicine, Hue, Vietnam (GRID:grid.440798.6)
4 Biomedicine Research Center Pham Ngoc Thach University of Medicine, Ho Chi Minh City, Vietnam (GRID:grid.412497.d) (ISNI:0000 0004 4659 3788); Saigon Precision Medicine Research Center, Ho Chi Minh City, Vietnam (GRID:grid.412497.d); Bone and Muscle Research Group Ton Duc Thang University, Ho Chi Minh City, Vietnam (GRID:grid.444948.1) (ISNI:0000 0004 0498 7850)
5 Saigon Precision Medicine Research Center, Ho Chi Minh City, Vietnam (GRID:grid.444948.1); University of Technology Sydney, School of Biomedical Engineering, Ultimo, Australia (GRID:grid.117476.2) (ISNI:0000 0004 1936 7611)
6 Tam Anh Research Institute, Tam Anh Hospital, Ho Chi Minh City, Vietnam (GRID:grid.513952.9); University of Technology Sydney, School of Biomedical Engineering, Ultimo, Australia (GRID:grid.117476.2) (ISNI:0000 0004 1936 7611)